Is it safe?
Can COGT take a bad year?
Cogent Biosciences, Inc. holds $569M more cash than debt, and is burning $77M a quarter, about 2.5 years of cover.
$569M
Net cash
- Net debt / EBITDA
- net cash
Net debt / EBITDA · no net borrowings to measure against earnings
- Cash runway
- 2.5 years
Cash runway · burning $77M a quarter at the current rate
- Annualised volatility
- 104%
Annualised volatility · three times the market's own swing
Details›
- Total debtQ2 2026
- $223M
- Cash and short-term investments
- $792M
- Net cash
- $569M
- EBITDA, trailing twelve months
- −$386M
- Operating profit, trailing twelve months
- −$389M
- Debt / equity
- 0.42×
- Annualised volatilitytwo years of daily moves
- 104%
- Worst drawdown on file
- −98%
- Below its 52-week high
- −14%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.